Obstructive Sleep Apnea Treatment with Oral Appliance in a Myotonic Dystrophy Type I Subject: A Case Report

Maria de Lourdes Rabelo Guimarães; Milena Carvalho Tourino Ribeiro; Thiago Antunes da Silva Barbosa; Laila Gabriela de Figueiredo Costa; Patricia Souza Bastos

doi:10.1055/s-0043-1772817

Sleep Science, Inhaltsverzeichnis

CC BY-NC-ND 4.0 · Sleep Sci 2023; 16(03): e375-e380
DOI: 10.1055/s-0043-1772817

Case Report

Obstructive Sleep Apnea Treatment with Oral Appliance in a Myotonic Dystrophy Type I Subject: A Case Report

Authors

Maria de Lourdes Rabelo Guimarães

¹Universidade Federal de Minas Gerais, Centro de Tecnologia em Medicina Molecular, Belo Horizonte, Minas Gerais, Brazil.
Milena Carvalho Tourino Ribeiro

²Centro Universitário de Belo Horizonte, Faculty of Dentistry, Belo Horizonte, Minas Gerais, Brazil.
Thiago Antunes da Silva Barbosa

²Centro Universitário de Belo Horizonte, Faculty of Dentistry, Belo Horizonte, Minas Gerais, Brazil.
Laila Gabriela de Figueiredo Costa

³Newton Paiva, Faculty of Dentistry, Belo Horizonte, Minas Gerais, Brazil.
Patricia Souza Bastos

⁴Rede Sarah de Hospitais de Reabilitação, Setor de Eletrodiagnósticos, Belo Horizonte, Minas Gerais, Brazil.

Abstract

Objective to report a myotonic dystrophy type 1 (MD1) subject with obstructive sleep apnea syndrome treated with oral appliance.

Methods A review of individual's history and records, associated with a photographic register of all diagnostic methods and literature research about the topic were done.

Final Statements This case depicts the therapeutical choices disposable to treat subjects with obstructive sleep apnea and DM1. Although considered an uncommon treatment, the oral appliances, if well indicated in adequately selected cases, can satisfactorily improve respiratory parameters, symptoms and quality of life.

Keywords

myotonic dystrophy type 1 - sleep apnea syndromes - sleepiness - oral appliance - biomarker - therapeutics

Volltext

Referenzen

References
1 Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol 2012; 11 (10) 891-905
2 Poussel M, Thil C, Kaminsky P. et al. Lack of correlation between the ventilatory response to CO2 and lung function impairment in myotonic dystrophy patients: evidence for a dysregulation at central level. Neuromuscul Disord 2015; 25 (05) 403-408
3 Ashizawa T, Gagnon C, Groh WJ. et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 2018; 8 (06) 507-520
4 Wenninger S, Montagnese F, Schoser B. Core clinical phenotypes in myotonic dystrophies. Front Neurol 2018; 9: 303
5 Bhat S, Gupta D, Chokroverty S. Sleep disorders in neuromuscular diseases. Neurol Clin 2012; 30 (04) 1359-1387
6 Gutiérrez Gutiérrez G, Díaz-Manera J, Almendrote M. et al. Clinical guide for the diagnosis and follow-up of myotonic dystrophy type 1, MD1 or Steinert's disease. Med Clin (Barc) 2019; 153 (02) 82.e1-82.e17
7 Barnes M, McEvoy RD, Banks S. et al. Efficacy of positive airway pressure and oral appliance in mild to moderate obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170 (06) 656-664
8 Lim J, Lasserson TJ, Fleetham J, Wright J. Oral appliances for obstructive sleep apnoea. Cochrane Database Syst Rev 2006; 2006 (01) CD004435
9 Mogell K, Blumenstock N, Mason E, Rohatgi R, Shah S, Schwartz D. Definition of an Effective Oral Appliance for the Treatment of Obstructive Sleep Apnea and Snoring: An Update for 2019. J Dent Sleep Med 2019;6(03):
10 Guimarães MLR, Oliveira JJM, Azevedo PG. Aparelho PLP para tratamento de ronco e apneia obstrutiva do sono. Orthod. Sci. Pract. 2015; 8 (29) 113-117
11 Hoffstein V. Review of oral appliances for treatment of sleep-disordered breathing. Sleep Breath 2007; 11 (01) 1-22
12 Ramar K, Dort LC, Katz SG. et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med 2015; 11 (07) 773-827
13 Petri N, Christensen IJ, Svanholt P, Sonnesen L, Wildschiødtz G, Berg S. Mandibular advancement device therapy for obstructive sleep apnea: a prospective study on predictors of treatment success. Sleep Med 2019; 54: 187-194
14 Poon KH, Chay SH, Chiong KF. Airway and craniofacial changes with mandibular advancement device in Chinese with obstructive sleep apnoea. Ann Acad Med Singap 2008; 37 (08) 637-644
15 Liu Y, Zeng X, Fu M, Huang X, Lowe AA. Effects of a mandibular repositioner on obstructive sleep apnea. Am J Orthod Dentofacial Orthop 2000; 118 (03) 248-256
16 Chi L, Comyn FL, Mitra N. et al. Identification of craniofacial risk factors for obstructive sleep apnoea using three-dimensional MRI. Eur Respir J 2011; 38 (02) 348-358
17 Rosen IM, Kirsch DB, Chervin RD. et al; American Academy of Sleep Medicine Board of Directors. Clinical use of a home sleep apnea test: an American Academy of Sleep Medicine position statement. J Clin Sleep Med 2017; 13 (10) 1205-1207
18 Doff MH, Hoekema A, Pruim GJ, Huddleston Slater JJ, Stegenga B. Long-term oral-appliance therapy in obstructive sleep apnea: a cephalometric study of craniofacial changes. J Dent 2010; 38 (12) 1010-1018
19 Tsuda H, Almeida FR, Tsuda T, Moritsuchi Y, Lowe AA. Craniofacial changes after 2 years of nasal continuous positive airway pressure use in patients with obstructive sleep apnea. Chest 2010; 138 (04) 870-874